ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - July 1959

Decade

Year

Issue

March 2022, Vol 79, No. 3, Pages 209-313

Viewpoint

Bringing Alzheimer Disease Testing and Results Disclosure Into the 21st Century Cures Act

Abstract Full Text
JAMA Neurol. 2022;79(3):219-220. doi:10.1001/jamaneurol.2021.4851

This Viewpoint discusses the pros and cons of the 21st Century Cures Act for Alzheimer disease–related testing and results disclosure.

The End Justifies the Means—A Call for Nuance in the Increasing Nationwide Adoption of Stereoelectroencephalography Over Subdural Electrode Monitoring in the Surgical Evaluation of Intractable Epilepsy

Abstract Full Text
JAMA Neurol. 2022;79(3):221-222. doi:10.1001/jamaneurol.2021.4994

This Viewpoint discusses the considerations that should guide decision-making on the choice of stereoelectroencephalography vs subdural monitoring in each patient.

On the Brain

The Best Bad News

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):223-224. doi:10.1001/jamaneurol.2021.5113

This essay describes the author’s symptom progression and eventual diagnosis of cancer during the COVID-19 pandemic.

Editorial

Prevalence Rates of Amyloid Positivity—Updates and Relevance

Abstract Full Text
JAMA Neurol. 2022;79(3):225-227. doi:10.1001/jamaneurol.2021.5225
Original Investigation

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):228-243. doi:10.1001/jamaneurol.2021.5216

This cross-sectional study evaluates amyloid biomarkers on positron emission tomography scans and in cerebrospinal fluid in individuals with normal cognition, subjective cognitive decline, mild cognitive impairment, or clinical Alzheimer disease dementia.

Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy: A Post Hoc Analysis of a Randomized Clinical Trial

Abstract Full Text
free access has audio
JAMA Neurol. 2022;79(3):244-250. doi:10.1001/jamaneurol.2021.4905

This post hoc analysis of a randomized clinical trial investigates whether the association of clopidogrel-aspirin treatment with stroke recurrence in patients with minor stroke or high-risk transient ischemic attack is modified by the presence of infarct on imaging attributed to the index event.

Durability of Clinical and Quality-of-Life Outcomes of Closed-Loop Spinal Cord Stimulation for Chronic Back and Leg Pain: A Secondary Analysis of the Evoke Randomized Clinical Trial

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):251-260. doi:10.1001/jamaneurol.2021.4998

This secondary analysis of a randomized clinical trial determines whether evoked compound action potentials–controlled, closed-loop spinal cord stimulator is associated with better outcomes compared with fixed-output, open-loop spinal cord stimulator at 24 months following implant.

Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):261-270. doi:10.1001/jamaneurol.2021.5181

This cross-sectional study investigates whether site-specific tau phosphorylation occupancy is associated with BDNF Val66Met in presymptomatic and symptomatic dominantly inherited Alzheimer disease.

Association of Ischemic Stroke Incidence, Severity, and Recurrence With Dementia in the Atherosclerosis Risk in Communities Cohort Study

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):271-280. doi:10.1001/jamaneurol.2021.5080

This cohort study evaluates the association between risk of dementia and incident ischemic stroke by stroke severity and recurrence.

Comparison of Mobile Stroke Unit With Usual Care for Acute Ischemic Stroke Management: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):281-290. doi:10.1001/jamaneurol.2021.5321

This systematic review and meta-analysis investigates whether mobile stroke unit use is associated with better functional outcomes in patients with acute ischemic stroke.

Review

Amyloid-Related Imaging Abnormalities and β-Amyloid–Targeting Antibodies: A Systematic Review

Abstract Full Text
has active quiz
JAMA Neurol. 2022;79(3):291-304. doi:10.1001/jamaneurol.2021.5205

This systematic review summarizes published data on amyloid-related imaging abnormalities from published studies of monoclonal antibodies targeting β-amyloid in adults with Alzheimer disease.

Images in Neurology

Magnetic Resonance Imaging Features of Tropical Candidal Meningoencephalitis

Abstract Full Text
has active quiz
JAMA Neurol. 2022;79(3):305-306. doi:10.1001/jamaneurol.2021.4947

This case report describes the imaging features of a 66-year-old woman with earache and headache, mild left-sided weakness, and intermittent hallucinations and nonsensical speech who received a diagnosis of Candida tropicalis.

Research Letter

Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination

Abstract Full Text
open access has active quiz
JAMA Neurol. 2022;79(3):307-309. doi:10.1001/jamaneurol.2021.5109

This cohort study investigates the immunogenicity and safety of a third SARS-CoV-2 vaccine dose in patients with multiple sclerosis who had a weak immune response to COVID-19 vaccination.

Comment & Response

Comments on the Evaluation of Suicidality Risk of Newer Antiseizure Medications

Abstract Full Text
JAMA Neurol. 2022;79(3):309-310. doi:10.1001/jamaneurol.2021.5138

Comments on the Evaluation of Suicidality Risk of Newer Antiseizure Medications—Reply

Abstract Full Text
JAMA Neurol. 2022;79(3):310-311. doi:10.1001/jamaneurol.2021.5141

Disentangling Workflow Paradigms and Treatment Decision-making in Acute Ischemic Stroke

Abstract Full Text
JAMA Neurol. 2022;79(3):311-312. doi:10.1001/jamaneurol.2021.5343

Disentangling Workflow Paradigms and Treatment Decision-Making in Acute Ischemic Stroke—Reply

Abstract Full Text
JAMA Neurol. 2022;79(3):312. doi:10.1001/jamaneurol.2021.5346
Correction

Error in Figure

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):312. doi:10.1001/jamaneurol.2021.5146

Error in Title

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):312-313. doi:10.1001/jamaneurol.2021.5165

Error in Methods

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):313. doi:10.1001/jamaneurol.2021.5446

Error in Figure Captions

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):313. doi:10.1001/jamaneurol.2021.5444

Error in Figure

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):313. doi:10.1001/jamaneurol.2021.5455

Errors in the Author Affiliations and Figure 1 Legend

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):313. doi:10.1001/jamaneurol.2022.0265

Error in Figure Legends

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):313. doi:10.1001/jamaneurol.2022.0335
JAMA Neurology Masthead

JAMA Neurology

Abstract Full Text
free access
JAMA Neurol. 2022;79(3):209. doi:10.1001/jamaneurol.2021.3758
×